Blog
RSS FeedPosted by Michael Wonder on 08 Aug 2019
Insurers snooping in our health records
9 August 2019 - Life insurers have trawled through the medical records of 150,000 Australians in an attempt to deny ...
Posted by Michael Wonder on 06 Aug 2019
Novartis hid manipulated data while seeking approval for $2.1 million treatment
6 August 2019 - The failure to report the issue has not put patients at risk, the F.D.A. said, but the ...
Posted by Michael Wonder on 06 Aug 2019
Statement on data accuracy issues with recently approved gene therapy
6 August 2019 - As a public health agency, we believe that it is critical to facilitate the development of ...
Posted by Michael Wonder on 21 Jul 2019
Sharing of clinical trial data and results reporting practices among large pharmaceutical companies: cross sectional descriptive study and pilot of a tool to improve company practices
21 July 2019 - The objective was to develop and pilot a tool to measure and improve pharmaceutical companies’ clinical trial ...
Posted by Michael Wonder on 16 Jul 2019
Gilead and Novartis seek to expand what FDA considers as real-world data and real-world evidence
15 July 2019 - Just over two months ago, the US FDA released draft guidance explaining to drugmakers what constitutes ...
Posted by Michael Wonder on 15 Jul 2019
Academies call on health minsters to resolve health data issues
15 July 2019 - Regulatory barriers that limit timely access to population and health data must be resolved to achieve ...
Posted by Michael Wonder on 04 Jul 2019
Attempt to replicate clinical trials with real world data generates real world criticism, too
3 July 2019 - It’s one of the most seductive ideas in medicine: that “real-world evidence,” including data from electronic ...
Posted by Michael Wonder on 29 Jun 2019
NICE explores extending its use of data to inform its guidance
25 June 2019 - NICE has revised its earlier press release on the use of real world data to inform ...
Posted by Michael Wonder on 26 Jun 2019
Use real world data, not international reference pricing to set US drug prices
25 June 2019 - The Trump administration has proposed using international reference pricing for medicines. ...
Posted by Michael Wonder on 13 May 2019
Two words to help Ned Sharpless revolutionise clinical trials: data standards
13 May 2019 - In the classic 1967 film “The Graduate,” young Benjamin Braddock was given one word of advice ...
Posted by Michael Wonder on 13 Mar 2019
Rx drug costs: list prices versus net prices and the importance of staying within the data
13 March 2019 - The authors of a recent Health Affairs article asked a meaningful question: Are new drugs or ...
Posted by Michael Wonder on 27 Feb 2019
Patient experience data and bias — what ratings don’t tell us
28 February 2018 - Although patient-experience data are important to U.S. health care organisations, the best way to interpret them remains ...
Posted by Michael Wonder on 20 Feb 2019
My Health Record opt-out doubles to 2.5 million people
20 February 2019 - The number of Australians who opted out of the My Health Record system doubled after the ...
Posted by Michael Wonder on 19 Feb 2019
Big opportunities in big data, but EMA and industry just getting started
18 February 2019 - 250m genomes sequenced, but data trapped in silos. ...
Posted by Michael Wonder on 19 Feb 2019
My Health Record reflects 'new consensus', says CEO Tim Kelsey
19 February 2019 - The government's controversial My Health Record was part of a "new consensus" on digital health, said ...